Log in
Enquire now
Somagenetix

Somagenetix

Somagenetix is a gene therapy developer for phagocyte disorders founded in 2019 by Ulrich Siler .

OverviewStructured DataIssuesContributors

Contents

somagenetix.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Biotechnology
Biotechnology
Pharmaceutical industry
Pharmaceutical industry
Health technology
Health technology
Location
Switzerland
Switzerland
Zürich
Zürich
Founder
‌
Ulrich Siler
‌
Janine Reichenbach
Number of Employees (Ranges)
1 – 10
Email Address
info@somagenetix.com
Investors
VI Partners
VI Partners
‌
Schroders Capital
Verve Ventures
Verve Ventures
Zurich Kantonal Bank
Zurich Kantonal Bank
Founded Date
2019
Total Funding Amount (USD)
11,661,000
Latest Funding Round Date
October 10, 2024
Latest Funding Type
Series A
Series A

Other attributes

Latest Funding Round Amount (USD)
11,661,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Somagenetix

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.